Skip to main content
. 2016 Nov 8;115(11):1313–1320. doi: 10.1038/bjc.2016.348

Figure 2.

Figure 2

FOSI change from baseline to 6 months for (A) the overall population and patients with (B) BRCAm and (C) gBRCAm. Worsening of FOSI indicated with a negative score. Olaparib/Placebo indicates the number of patients who completed the assessment at each time point. Abbreviations: CI=confidence interval; LSM=least squares mean.